Form 4: Chewy CTO Sells Shares Under 10b5-1 Plan

Chewy's Chief Technology Officer, Satish Mehta, sold 46,765 shares of Class A Common Stock for $34.69 per share under a pre-arranged trading plan.

Summary

• Satish Mehta, Chief Technology Officer of Chewy, Inc. (CHWY), reported a sale of 46,765 shares of Class A Common Stock on September 15, 2025.
• The shares were sold at a price of $34.69 per share, totaling approximately $1,621,900.85.
• The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 9, 2025.
• Following this transaction, Mehta directly beneficially owns 229,702 shares of Class A Common Stock.
• Mehta also holds various contingent equity awards, including 64,931 performance-based restricted stock units (PRSUs) from an April 6, 2023 grant, which vested on February 1, 2026, after performance conditions were certified on March 22, 2024.
• An additional 27,056 restricted stock units (RSUs) from an April 6, 2023 grant are subject to time-vesting, with 33.33% vesting on February 1, 2026, and subsequent six-month anniversaries, and 6,764 of these vesting 100% on February 1, 2026.
• Further contingent holdings include 162,139 PRSUs from an April 4, 2024 grant, which vested on February 1, 2027, after performance conditions were certified on March 26, 2025.
• Mehta holds 62,097 RSUs granted on April 8, 2025, with 25% vesting on March 1, 2026, and 6.25% vesting on each three-month anniversary thereafter.
• Another 94,235 RSUs granted on April 4, 2024, have vesting schedules including 8.41% on November 1, 2025, 15.84% on December 1, 2025, and 8.41% on February 1, 2026, and each three-month anniversary thereafter.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the execution under a Rule 10b5-1 plan mitigates this concern, suggesting a pre-planned liquidity event rather than a reaction to new information. The ongoing significant equity grants (RSUs and PRSUs) to the CTO are a positive for executive retention and alignment with long-term company performance.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than an immediate reaction to new information.
• Performance conditions for the 2023 and 2024 PRSUs were certified, indicating the company met its targets for those fiscal years.
• Ongoing grants of RSUs and PRSUs demonstrate continued executive compensation and retention strategies, aligning management's long-term interests with shareholder value.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by the market, although the 10b5-1 plan mitigates this concern.

Risks

• No specific risks beyond general market perception of insider sales are mentioned in this Form 4 filing.

Future Outlook

The future outlook for Satish Mehta's equity holdings includes the vesting of significant tranches of performance-based restricted stock units (PRSUs) and restricted stock units (RSUs) through early 2027, contingent on continued employment. These vesting events will periodically increase his beneficially owned shares.

Management Comments

• The sale was executed under a Rule 10b5-1 trading plan adopted on April 9, 2025, indicating a pre-scheduled transaction.

Industry Context

Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock ownership changes. The use of a Rule 10b5-1 trading plan is a common practice among corporate executives to manage personal stock sales in a pre-arranged manner, mitigating concerns about trading on material non-public information. This filing is consistent with typical insider activity for a publicly traded company.

Comparison to Industry Standards

• NA. This Form 4 filing details a routine insider transaction and equity grants, which are standard practices across publicly traded companies. It does not contain information that allows for specific comparisons to industry-wide financial results, projects, or operational benchmarks.

Stakeholder Impact

• Shareholders: Minor impact due to a routine insider sale. The pre-planned nature of the sale under a 10b5-1 plan reduces potential negative interpretations.
• Employees: The ongoing equity grants to the Chief Technology Officer indicate continued executive retention and incentive alignment.

Next Steps

• Continued vesting of 64,931 PRSUs on February 1, 2026.
• Continued vesting of 27,056 RSUs, with portions vesting on February 1, 2026, and subsequent six-month anniversaries.
• Continued vesting of 94,235 RSUs, with portions vesting on November 1, 2025, December 1, 2025, February 1, 2026, and subsequent three-month anniversaries.
• Continued vesting of 62,097 RSUs, with portions vesting on March 1, 2026, and subsequent three-month anniversaries.
• Continued vesting of 162,139 PRSUs on February 1, 2027.

Key Dates

Recommendation

This Form 4 filing details a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which typically signals a planned liquidity event rather than a change in management's outlook on the company's prospects. While insider sales can sometimes be viewed negatively, the pre-scheduled nature mitigates this concern. The filing also highlights significant ongoing equity grants (RSUs and PRSUs) to the Chief Technology Officer, indicating continued alignment of management incentives with shareholder value and a commitment to executive retention. There are no new material financial disclosures or strategic shifts that would warrant a change in investment posture based solely on this filing. Therefore, a 'hold' recommendation is appropriate as the information presented does not provide a strong catalyst for either buying or selling.

Keywords

Chewy, CHWY, Insider Trading, Form 4, Stock Sale, Satish Mehta, CTO, 10b5-1 Plan, Restricted Stock Units, Performance-Based Restricted Stock Units, Equity Compensation